At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 79 enrolled
Drug / intervention
Carboxymethylcellulose Sodium Based Eye Drops +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief
In Brief
A Phase 3 clinical trial evaluating Carboxymethylcellulose Sodium Based Eye Drops, Systane® Gel Drops, and 1 other intervention for Dry Eye Syndromes. Completed, enrolled 79 participants across 1 site.
Detailed Summary
A study to evaluate the tolerability and acceptability of an investigational eye drop formulation in patients with Dry Eye Disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndromes
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartDec 2014
First PostedMay 2015
Primary CompletionAug 2015
TodayJul 2026
First PostedMay 27, 2015
Enrollment StartDec 1, 2014
Primary CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 11.1 years ago
Interventions
Carboxymethylcellulose Sodium Based Eye Dropsdrug
1 to 2 drops of Carboxymethylcellulose Sodium Based Eye Drops \[New Eye Drop Formula\] in each eye.
Systane® Gel Dropsdrug
1 to 2 drops of Systane® Gel Drops in each eye.
Genteal® Lubricant Gel Dropsdrug
1 to 2 drops of Genteal® Lubricant Gel Drops in each eye.